InflaRx (IFRX) Equity Average (2023 - 2025)

InflaRx (IFRX) has disclosed Equity Average for 3 consecutive years, with $57.0 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 35.23% to $57.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.0 million through Dec 2025, down 35.23% year-over-year, with the annual reading at $57.0 million for FY2025, 35.44% down from the prior year.
  • Equity Average hit $57.0 million in Q4 2025 for InflaRx, down from $88.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $100.3 million in Q4 2023 to a low of $57.0 million in Q4 2025.
  • Historically, Equity Average has averaged $81.8 million across 3 years, with a median of $88.0 million in 2024.
  • Biggest five-year swings in Equity Average: fell 12.22% in 2024 and later plummeted 35.23% in 2025.
  • Year by year, Equity Average stood at $100.3 million in 2023, then fell by 12.22% to $88.0 million in 2024, then tumbled by 35.23% to $57.0 million in 2025.
  • Business Quant data shows Equity Average for IFRX at $57.0 million in Q4 2025, $88.0 million in Q4 2024, and $100.3 million in Q4 2023.